Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma.
| Autor: | Eggermont AM, Suciu S, Testori A, Santinami M, Kruit WH, Marsden J, Punt CJ, Salès F, Dummer R, Robert C, Schadendorf D, Patel PM, de Schaetzen G, Spatz A, Keilholz U, Eggermont, Alexander M M, Suciu, Stefan, Testori, Alessandro, Santinami, Mario, Kruit, Wim H J |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 11/1/2012, Vol. 30 Issue 31, p3810-3818, 9p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|